Table 2.
Summary of primary outcome measures and expected results
| Primary outcome | Measurement method | Estimated outcomes | |
|---|---|---|---|
| Placebo | Fenofibrate | ||
| AAA-wall OPN concentration (pg/mg) | ELISA | 210 ± 145 | 84 ± 87 |
| AAA-wall macrophages (per mm2 section) | IHC | 4.9 ± 1.8 | 2.4 ± 1.8 |
| Serum OPN concentration (ng/mL) | ELISA | 77 ± 32 | 46 ± 32 |
AAA abdominal aortic aneurysm, ELISA enzyme-linked immunosorbent assay, IHC immunohistochemistry, OPN osteopontin